Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639817 · ClinicalTrials.gov registry record
Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,621
- Enrollment target
NCT04639817: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT04639817 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,621 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04639817 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,621 participants
- Enrollment target
Study Summary
This study seeks to compare mortality outcomes of levofloxacin and trimethoprim-sulfamethoxazole treated patients who have Stenotrophomonas maltophilia blood stream or lower respiratory tract infections by retrospectively analyzing a propensity-matched cohort from a large dataset of electronic health record data.
Primary Outcome
Patient died or discharged to hospice
Interventions
- DRUG trimethoprim-sulfamethoxazole
- DRUG Levofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,621 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2021-04-27 |
What the finished NCT04639817 record still lists
NCT04639817 is an observational study that tracks outcomes without assigning an intervention. Its 1,621 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which trimethoprim-sulfamethoxazole is the first listed.
NCT04639817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04639817 about?
NCT04639817 is a clinical study titled "Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study". This study seeks to compare mortality outcomes of levofloxacin and trimethoprim-sulfamethoxazole treated patients who have Stenotrophomonas maltophilia blood stream or lower respiratory tract infections by retrospectively analyzing a propensity-matched cohort from a large dataset of electronic healt...
What is the current status of trial NCT04639817?
This trial is currently completed. The enrollment target is 1,621 participants. The study started on 2020-08-14. Estimated completion is 2021-04-27.
What interventions are being tested in trial NCT04639817?
The interventions under investigation include: trimethoprim-sulfamethoxazole (DRUG), Levofloxacin (DRUG).
Who is sponsoring clinical trial NCT04639817?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI